Journal
THERAPEUTICS AND CLINICAL RISK MANAGEMENT
Volume 15, Issue -, Pages 965-977Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/TCRM.S204909
Keywords
antibodies; monoclonal; drug-related side effects and adverse reactions; nurse practitioners
Categories
Funding
- Regional Goverment of Extremadura
- European Regional Development Fund (FEDER) [IB18101]
Ask authors/readers for more resources
Monoclonal antibodies constitute important and useful tools in clinical practice and biotechnology for diagnosing and treating infectious, inflammatory, immunological and neoplastic diseases. This article reviews evidence on the different acute adverse effects of monoclonal antibodies, specifically infusion-related reactions (IRRs), and on the measures that should be taken before and during crises. A literature search using key terms relating to IRRs produced by monoclonal antibodies was undertaken to generate a comprehensive narrative review of the information available. Immunomodulatory monoclonal antibodies may produce IRRs and hypersensitivity-related reactions. Strategies to avoid or minimize the appearance of IRRs depend on the monoclonal antibody and type of patient and reaction (pre-medication, slowing infusion rates, infusion interruption or desensitization, etc.). Considering the great number of available monoclonal antibodies in current practice and those which will soon be authorized, it is mandatory to have clear guidelines that can give support to practitioners and nurses to help them respond quickly and safely to the different IRRs related to the use of these therapeutic drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available